New CAR T-Cell therapy targets Tough-to-Treat blood cancer
Disease control
Recruiting now
This study is testing an experimental cell therapy called MB-105 for adults with a type of blood cancer called T-cell lymphoma that has come back or not responded to standard treatments. MB-105 is a CAR T-cell therapy, which involves modifying a patient's own immune cells to targ…
Phase: PHASE2 • Sponsor: March Biosciences Inc • Aim: Disease control
Last updated Apr 01, 2026 23:10 UTC